 |
 |
Anthrax
|
For comprehensive CDC information about bioterrorism
and related issues, please visit http://www.bt.cdc.gov.
|
Related Internet Sites
CDC Emergency Preparedness and Response
http://www.cdc.gov/agent/anthrax/index.aspCDC National Center for Infectious Diseases
http://www.cdc.gov/ncidod/diseases/submenus/sub_anthrax.htmCDC National Immunization Program
http://www.cdc.gov/nip/diseases/anthraxDepartment of Defense Anthrax Vaccine Immunization Program
http://www.anthrax.osd.mil/Jernigan JA, Stephens DS, Ashford DA, et al. Bioterrorism-related inhalational anthrax: the first 10 cases reported in the United States. Emerg Infect Dis 2001; 7: 933-944.
http://www.cdc.gov/ncidod/EID/vol7no6/jerniganG8.htm
References
Use of anthrax vaccine in the United States, Advisory Committee on Immunization Practices. MMWR 2000; 49 RR-15: 1-20, and Notice to Readers: Use of anthrax vaccine in response to terrorism: supplemental recommendations of the Advisory Committee on Immunization Practices. MMWR 2002; 45 RR-15: 1024-1026.
CDC. Update: Investigation of bioterrorism-related anthrax and interim guidelines for exposure management and antimicrobial therapy, October 2001. MMWR 2001; 50: 909-919.
Jernigan DB, Raghunathan PL, Bell BP, et al. Investigation of bioterrorism-related anthrax, United States, 2001: epidemiologic findings. Emerg Infect Dis 2002; 8: 1019-1028.
Hoffmaster AR, Meyer, RF, Bowen MB, et al. Evaluation and validation of real-time PCR assay for rapid identification of Bacillus anthracis. Emerg Infect Dis 2002; 8: 1178-1181.
Hoffmaster A, Fitzgerald V, Ribot E, Mayer LW, Popovic T. Importance of molecular subtyping of Bacillus anthracis during recent-multi-state bioterrorism associated anthrax outbreak in the United States. Emerg Infect Dis 2002; 8: 1111-1116.
Sacchi CT, Whitney AM, Mayer LW, Morey R, Steigerwalt A, Boras A, Popovic T. Sequencing of the 16S rDNA gene: rapid tool for identification of Bacillus anthracis. Emerg Infect Dis 2002; 8: 1117-1123.